Who owns BIOXCEL THERAPEUTICS INC COM NEW?
- Ticker: BTAI
- CUSIP Number: 09075p204
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioxcel Therapeutics stock
Who bought or sold BIOXCEL THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 1.0M | $2.6M | 100% | Sep 2025 |
|
| Vanguard Group | 293k | $468k | 52% | Dec 2025 |
|
| Oaktree Capital Management | 241k | $617k | 0% | Sep 2025 |
|
| Geode Capital Management | 206k | $330k | 65% | Dec 2025 |
|
| FMR | 199k | $508k | 100% | Sep 2025 |
|
| Jones Financial Companies, L.L | 138k | $220k | 282% | Dec 2025 |
|
| Jane Street | 128k | $204k | 100% | Dec 2025 |
|
| GSA Capital Partners | 120k | $192k | 100% | Dec 2025 |
|
| BlackRock | 84k | $135k | 0% | Dec 2025 |
|
| State Street Corporation | 63k | $101k | 20% | Dec 2025 |
|
| Man Group | 57k | $91k | 100% | Dec 2025 |
|
| Oaktree Fund Advisors | 43k | $69k | 0% | Dec 2025 |
|
| HighTower Advisors | 41k | $66k | 17% | Dec 2025 |
|
| Northern Trust | 38k | $61k | 2% | Dec 2025 |
|
| UBS Group | 38k | $61k | -12% | Dec 2025 |
|
| Hrt Financial | 18k | $28k | 100% | Dec 2025 |
|
| Two Sigma Securities | 17k | $27k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 16k | $25k | 4% | Dec 2025 |
|
| Diversify Wealth Management | 15k | $31k | 0% | Dec 2025 |
|
| Engineers Gate Manager | 12k | $20k | 100% | Dec 2025 |
|
| Portfolio Strategies | 12k | $20k | 100% | Dec 2025 |
|
| IFP Advisors | 4.4k | $7.0k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 4.3k | $7.2k | -73% | Dec 2025 |
|
| Group One Trading | 3.2k | $5.1k | 42% | Dec 2025 |
|
| Goss Wealth Management | 1.3k | $2.1k | 0% | Dec 2025 |
|
| Caitong International Asset Management | 446.00 | $714.001400 | 100% | Dec 2025 |
|
| AllSquare Wealth Management | 175.00 | $448.000000 | 0% | Sep 2025 |
|
| SBI Securities | 169.00 | $269.994400 | 0% | Dec 2025 |
|
| Washington Trust Advisors | 160.00 | $256.000000 | 0% | Dec 2025 |
|
| Parkside Financial Bank & Trust | 112.00 | $179.995200 | 0% | Dec 2025 |
|
| Annis Gardner Whiting Capital Advisors | 112.00 | $179.995200 | 100% | Dec 2025 |
|
| EverSource Wealth Advisors | 60.00 | $96.000000 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 45.00 | $115.002000 | 100% | Sep 2025 |
|
| Farther Finance Advisors | 25.00 | $40.000000 | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 21.00 | $33.999000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 12.00 | $18.999600 | -69% | Dec 2025 |
|
| Zurcher Kantonalbank | 2.00 | $3.000000 | -98% | Dec 2025 |
|
| Us Bancorp | 1.00 | $2.000000 | 0% | Dec 2025 |
|
| Triumph Capital Management | 1.00 | $2.000000 | 100% | Dec 2025 |
|
Who sold out of Bioxcel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Sep 2025 | 113k | $290k |
| Foundations Investment Advisors | Sep 2025 | 30k | $76k |
| SLT Holdings | Sep 2025 | 30k | $76k |
| Citadel Advisors | Jun 2025 | 11k | $21k |
| Tower Research Capital | Sep 2025 | 3.9k | $10k |